Trajan Group Holdings Ltd
Trajan Group Holdings Ltd designs, develops, and distributes laboratory equipment and consumables, primarily serving the life sciences and healthcare sectors.
Business. Trajan Group Holdings Ltd (TRJ.AX) is a technology equipment company operating within the office equipment industry. The firm generates revenue primarily through the sale of products. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Trajan Group Holdings Ltd (TRJ.AX) is a technology equipment company operating within the office equipment industry. The firm generates revenue primarily through the sale of products. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
Trajan Group Holdings Ltd has a fully diluted share count of 152,593,045, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available in the valuation snapshot, and no industry_config preferred metrics are provided for comparison. This limits the ability to assess Trajan Group Holdings Ltd's performance relative to its peers in the Office Equipment industry.
Trajan Group Holdings Ltd's revenue is concentrated in the life sciences and healthcare sectors, as disclosed in its segments. No geographic breakdown is available, but the company's primary market is inferred to be Australia, given its listing on the Australian Securities Exchange.
Outlook data for the current and next fiscal years is not provided, and no numeric deltas are available to assess growth trajectory. Analysts have issued a mean price target of 1.03 AUD, with a median of 1.05 AUD, suggesting a neutral to slightly bullish sentiment.
Risk factors include the inability to assess liquidity risk and the absence of disclosed capital structure details. Dilution risk is currently low, as no dilutive instruments are outstanding. No recent filings or transcripts are available to identify material events or strategic shifts.
No recent events, such as earnings calls, regulatory filings, or strategic announcements, are available in the source documents to inform the company's current operational or strategic direction.
- Trajan Group Holdings Ltd operates in the life sciences and healthcare sectors, focusing on laboratory equipment and consumables.
- The company has no dilution risk from stock options or convertible securities, as basic and diluted shares are equal.
- Analysts have issued a neutral to slightly bullish outlook, with a mean price target of 1.03 AUD.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
- No growth trajectory or profitability metrics are available for comparison with industry peers.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue A$166.5M, +7,4% YoY; Operating income +112,8% YoY.
- ▍Revenue A$166.5M, +7,4% YoY
- ▍Operating income +112,8% YoY
- ▍Net income +82,4% YoY
- ▍Free cash flow +114,8% YoY
- ▍Net margin -2.7%
Revenue A$155.0M, −4,4% YoY; Operating income −405,9% YoY.
- ▍Revenue A$155.0M, −4,4% YoY
- ▍Operating income −405,9% YoY
- ▍Net income −1 440,9% YoY
- ▍Free cash flow −1 404,3% YoY
- ▍Net margin -16.3%
Revenue A$162.2M, +50,7% YoY; Operating income +288,1% YoY.
- ▍Revenue A$162.2M, +50,7% YoY
- ▍Operating income +288,1% YoY
- ▍Net income +70,5% YoY
- ▍Free cash flow −36,0% YoY
- ▍Net margin 1.2%
Revenue A$107.6M, +40,5% YoY; Operating income +1 130,4% YoY.
- ▍Revenue A$107.6M, +40,5% YoY
- ▍Operating income +1 130,4% YoY
- ▍Net income −41,1% YoY
- ▍Free cash flow +340,6% YoY
- ▍Net margin 1.0%
Revenue A$76.6M; Operating income -A$217.0k.
- ▍Revenue A$76.6M
- ▍Operating income -A$217.0k
- ▍Net margin 2.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,03 |
| Revenue | —no estimate | —no estimate | 171,3M AUD |
| Operating income | —no estimate | —no estimate | 8,0M AUD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Trajan Group Holdings Ltd Market data — financials · 2026-05-29
- Trajan Group Holdings Ltd Market data — analyst estimates · 2026-05-29